Gradient Investments LLC Buys 16,950 Shares of Procter & Gamble Company (The) $PG

Gradient Investments LLC increased its stake in shares of Procter & Gamble Company (The) (NYSE:PG) by 6.8% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 267,216 shares of the company’s stock after buying an additional 16,950 shares during the quarter. Gradient Investments LLC’s holdings in Procter & Gamble were worth $39,185,000 at the end of the most recent reporting period.

Other institutional investors have also bought and sold shares of the company. Brighton Jones LLC grew its stake in Procter & Gamble by 51.5% during the fourth quarter. Brighton Jones LLC now owns 40,068 shares of the company’s stock worth $6,717,000 after buying an additional 13,617 shares during the last quarter. Taylor Financial Group Inc. raised its stake in shares of Procter & Gamble by 10.6% in the first quarter. Taylor Financial Group Inc. now owns 2,891 shares of the company’s stock valued at $493,000 after acquiring an additional 277 shares during the last quarter. Sivia Capital Partners LLC boosted its holdings in shares of Procter & Gamble by 19.8% in the 2nd quarter. Sivia Capital Partners LLC now owns 6,144 shares of the company’s stock worth $979,000 after acquiring an additional 1,016 shares in the last quarter. Auxano Advisors LLC grew its position in Procter & Gamble by 10.8% during the 2nd quarter. Auxano Advisors LLC now owns 7,315 shares of the company’s stock worth $1,165,000 after acquiring an additional 714 shares during the last quarter. Finally, Schnieders Capital Management LLC. grew its position in Procter & Gamble by 2.8% during the 2nd quarter. Schnieders Capital Management LLC. now owns 30,182 shares of the company’s stock worth $4,809,000 after acquiring an additional 809 shares during the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.

Analyst Ratings Changes

PG has been the topic of a number of recent analyst reports. Citigroup reduced their price objective on Procter & Gamble from $181.00 to $170.00 and set a “buy” rating on the stock in a research note on Thursday, July 30th. Bank of America lowered their target price on Procter & Gamble from $170.00 to $166.00 and set a “buy” rating for the company in a research note on Friday, July 10th. Barclays upped their price target on shares of Procter & Gamble from $146.00 to $152.00 and gave the stock an “equal weight” rating in a research report on Tuesday, July 21st. Wells Fargo & Company increased their price objective on shares of Procter & Gamble from $158.00 to $164.00 and gave the stock an “overweight” rating in a report on Monday, April 27th. Finally, Jefferies Financial Group raised their price objective on shares of Procter & Gamble from $177.00 to $179.00 and gave the company a “buy” rating in a research report on Friday, June 26th. Thirteen equities research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company. According to MarketBeat.com, Procter & Gamble presently has an average rating of “Moderate Buy” and an average target price of $161.52.

Procter & Gamble Price Performance

Procter & Gamble stock opened at $145.88 on Friday. The company has a current ratio of 0.68, a quick ratio of 0.47 and a debt-to-equity ratio of 0.43. The firm has a market capitalization of $339.09 billion, a P/E ratio of 22.04, a PEG ratio of 4.52 and a beta of 0.39. The business has a 50-day moving average of $147.86 and a 200-day moving average of $148.98. Procter & Gamble Company has a 1 year low of $137.62 and a 1 year high of $167.25.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings results on Wednesday, July 29th. The company reported $1.43 earnings per share for the quarter, beating analysts’ consensus estimates of $1.41 by $0.02. Procter & Gamble had a net margin of 18.44% and a return on equity of 31.36%. The business had revenue of $21.20 billion for the quarter, compared to the consensus estimate of $21.38 billion. During the same period last year, the company posted $1.48 EPS. Procter & Gamble’s revenue for the quarter was up 1.5% on a year-over-year basis. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. On average, equities analysts anticipate that Procter & Gamble Company will post 6.99 EPS for the current year.

Procter & Gamble Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, August 17th. Stockholders of record on Friday, July 24th will be given a dividend of $1.0885 per share. This represents a $4.35 dividend on an annualized basis and a dividend yield of 3.0%. The ex-dividend date of this dividend is Friday, July 24th. Procter & Gamble’s dividend payout ratio (DPR) is currently 65.71%.

Procter & Gamble News Summary

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: PG’s $3.8 billion acquisition of Thorne would expand its presence in vitamins, supplements and wellness products, providing a potential avenue for longer-term growth beyond its traditional consumer-staples categories. Procter & Gamble making $3.8 billion acquisition of supplements company Thorne
• Positive Sentiment: PureCycle Technologies reported that its first commercial recycled-resin deliveries to PG have begun, with select Downy detergent caps now in production. The development supports PG’s sustainability efforts and could help secure recycled materials for packaging. PureCycle Technologies Reports Second Quarter 2026 Results
• Neutral Sentiment: PG continues to be highlighted as a defensive consumer-staples and dividend stock amid market volatility. However, elevated Treasury yields may make dividend-paying equities somewhat less attractive relative to bonds. 5 Solid Dividend Stocks to Buy in August
• Negative Sentiment: Argus downgraded PG from “buy” to “hold.” The change removes a positive analyst catalyst and likely reflects concerns about valuation, modest recent sales growth and limited near-term upside.
• Negative Sentiment: Discussion surrounding the Thorne acquisition has focused on product quality and safety concerns. Although these are not confirmed problems, such concerns could increase reputational and integration risks for PG as it enters the supplements market. Procter & Gamble Buys Supplement Brand Thorne — People Have Thoughts

Procter & Gamble Profile

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.